U.S. Court of Appeals for the Federal Circuit

U.S. Court of Appeals Stands Tall on the Subject of Gene Patents in the Wake of the Mayo v Prometheus Ruling

The United States Court of Appeals for the Federal Circuit, in the case Association for Molecular Pathology (AMP) and ACLU v. USPTO and Myriad Genetics (Myriad), held in August that isolated genes are a patent-eligible subject matter. The Court of Appeals reaffirmed its prior ruling on the matter, which was recently covered by IP Osgoode.